141.93
-1.44 (-1.00%)
| Penutupan Terdahulu | 143.37 |
| Buka | 140.99 |
| Jumlah Dagangan | 818,706 |
| Purata Dagangan (3B) | 850,900 |
| Modal Pasaran | 4,850,361,344 |
| Harga / Pendapatan (P/E TTM) | 55.88 |
| Harga / Pendapatan (P/E Ke hadapan) | 56.50 |
| Harga / Jualan (P/S) | 9.34 |
| Harga / Buku (P/B) | 13.02 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Oct 2025 |
| Margin Keuntungan | 10.03% |
| Margin Operasi (TTM) | 19.12% |
| EPS Cair (TTM) | 1.42 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 48.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 110.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 194.67% |
| Nisbah Semasa (MRQ) | 9.10 |
| Aliran Tunai Operasi (OCF TTM) | 49.38 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -84.81 M |
| Pulangan Atas Aset (ROA TTM) | 4.21% |
| Pulangan Atas Ekuiti (ROE TTM) | 22.99% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | TransMedics Group, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | 4.0 |
| Purata | 1.00 |
|
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 3.03% |
| % Dimiliki oleh Institusi | 121.56% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 166.00 (Needham, 16.96%) | Beli |
| Median | 144.00 (1.46%) | |
| Rendah | 135.00 (Morgan Stanley, -4.88%) | Pegang |
| Purata | 147.25 (3.75%) | |
| Jumlah | 3 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 134.02 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Canaccord Genuity | 17 Dec 2025 | 148.00 (4.28%) | Beli | 121.93 |
| 30 Oct 2025 | 147.00 (3.57%) | Beli | 135.79 | |
| Needham | 08 Dec 2025 | 166.00 (16.96%) | Beli | 136.60 |
| Morgan Stanley | 02 Dec 2025 | 135.00 (-4.88%) | Pegang | 141.77 |
| Piper Sandler | 30 Oct 2025 | 140.00 (-1.36%) | Beli | 135.79 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Jan 2026 | Pengumuman | TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts |
| 30 Dec 2025 | Pengumuman | TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference |
| 24 Dec 2025 | Pengumuman | TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
| 18 Nov 2025 | Pengumuman | TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference |
| 31 Oct 2025 | Pengumuman | TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
| 29 Oct 2025 | Pengumuman | TransMedics Reports Third Quarter 2025 Financial Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |